Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Featuring perspectives from Prof Thomas Powles, including the following topics:

• Circulating tumor DNA (ctDNA) analyses with adjuvant nivolumab for MIBC in the CheckMate 274 study (0:00)
• Use of ctDNA to guide response-adapted bladder preservation for patients with MIBC (2:27)
• ctDNA response-adapted treatment de-escalation for patients with metastatic urothelial carcinoma: The CT-READ trial (10:26)
• Emerging data and studies regarding urinary tumor DNA (18:04)

CME information and select publications